Kommentar
Ena-bile-ing liver cancer growth
Science · 10.01.2025 · 387 (6730) · 137-138
DOI: 10.1126/science.adu7928 ↗Kurz gefasst
Kommentar in der Zeitschrift Science, erschienen am 10.01.2025. Verfasst von Wolfram Goessling. Beteiligte Einrichtung: Gastroenterology Division, Massachusetts General Hospital, Boston, MA, USA. Hauptthemen laut MEDLINE: Bile Acids and Salts, Carcinoma, Hepatocellular, Liver Neoplasms, T-Lymphocytes. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 15 Literaturangaben.
Abstract (Originalsprache)
Bile acids differentially affect immune cell responses to liver cancer
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Bile Acids and SaltsCarcinoma, HepatocellularLiver NeoplasmsT-LymphocytesAnimalsHumansMiceImmunotherapy
Substanzen
Bile Acids and Salts
Autor:innen und Institutionen
- Gastroenterology Division, Massachusetts General Hospital, Boston, MA, USA.
- Genetics Division, Brigham and Women's Hospital, Boston, MA, USA.
- Harvard-MIT Division of Health Sciences and Technology, Broad Institute of MIT and Harvard, Boston, MA, USA.
- Harvard Stem Cell Institute, Harvard Medical School, Boston, MA, USA.
Zitieren
APA
Goessling, W. (2025). Ena-bile-ing liver cancer growth. Science, 387(6730), 137-138. https://doi.org/10.1126/science.adu7928
Vancouver
Goessling W. Ena-bile-ing liver cancer growth. Science. 2025;387(6730):137-138. doi:10.1126/science.adu7928
BibTeX
@article{Goessling2025,
author = {Goessling, Wolfram},
title = {Ena-bile-ing liver cancer growth},
journal = {Science},
year = {2025},
volume = {387},
number = {6730},
pages = {137--138},
doi = {10.1126/science.adu7928}
}
EUVIMED